Seeking Small-Cap Moats: Natus Medical
The company has built a leading market share in neurology and newborn care.
This article is part of Todd's monthly series "Seeking Small-Cap Moats." The introductory article can be found here. New articles in the series are published on the fourth Wednesday of every month.
About eight years ago, I listened to a compelling investment presentation on Natus Medical (BABY), which at the time was primarily focused on medical equipment designed for screening and monitoring newborn babies with hearing impairment, epilepsy, jaundice, and other conditions. After doing some further research, I bought some shares but sold them about a year later to help finance a down payment on a house.
Todd Wenning does not own shares in any of the securities mentioned above. Find out about Morningstar’s editorial policies.